(lp0
S'AcelRx Pharmaceuticals to Participate at Two Upcoming Investor Events in March PR Newswire  - Mar 1, 2017 REDWOOD CITY, Calif., March 1, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of&nbsp;...AcelRx Pharmaceuticals Inc  Set to Announce Earnings on Thursday - Sports Perspectives'
p1
aS'AcelRx Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results PR Newswire  - Mar 2, 2017 REDWOOD CITY, Calif., March 2, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain,&nbsp;...ACELRX PHARMACEUTICALS, INC.  Files An 8-K Other Events - Market Exclusive'
p2
aS'AcelRx Pharmaceuticals to Hold Annual 2016 Financial Results Conference Call ... PR Newswire  - Feb 23, 2017 REDWOOD CITY, Calif., Feb. 23, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe&nbsp;...'
p3
aS"Why AcelRx Pharmaceuticals Inc. Is Crashing Motley Fool - Mar 10, 2015 What's happening: Shares in AcelRx Pharmaceuticals  continued their decline today, falling by as much as 10% after the company reported disappointing fourth quarter results. The drop follows yesterday's 37% collapse on news that the FDA&nbsp;...AcelRx Pharmaceuticals  Stock Extends Losses Today as Jefferies Downgrades - TheStreet.com"
p4
aS"AcelRx Pharmaceuticals' ARX-04 Phase 3 Trial Met its Primary Endpoint, Reduced ... PR Newswire  - Aug 15, 2016 REDWOOD CITY, Calif., Aug. 15, 2016 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe&nbsp;..."
p5
aS'Company Update : AcelRx Pharmaceuticals Inc Submits New Drug ... Smarter Analyst - Dec 13, 2016 AcelRx Pharmaceuticals Inc  announced that it has submitted a New Drug Application  under section 505 with the U.S.'
p6
aS'AcelRx Pharmaceuticals: Blockbuster Potential Makes This $2 Stock A Strong Buy ... Seeking Alpha - Jan 10, 2017 AcelRx Pharmaceuticals shares appear deeply undervalued and could be poised for a short squeeze rally. This company has financial strength and two strong pipeline candidates, including a potential &quot;blockbuster&quot; that could get FDA approval in 2017.'
p7
aS'AcelRx Pharmaceuticals Presentation at JAB Burn Symposium Highlights Potential ... PR Newswire  - Feb 13, 2017 REDWOOD CITY, Calif., Feb. 13, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe&nbsp;...'
p8
aS'AcelRx Pharmaceuticals Appoints Gina Ford as Vice President Commercial Strategy PR Newswire  - Oct 1, 2015 REDWOOD CITY, Calif., Oct. 1, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, today&nbsp;...'
p9
aS'AcelRx Initiates Phase 3 Study of Zalviso in Patients with Moderate-to-Severe ... PR Newswire  - Sep 27, 2016 REDWOOD CITY, Calif., Sept. 27, 2016 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe&nbsp;...Stock Update : AcelRx Pharmaceuticals Inc Initiates Phase 3 Study ... - Smarter AnalystAcelRx launches late-stage study of pain med device Zalviso in hospital setting - Seeking Alpha'
p10
a.